EWA
Evolution Wealth Advisors Portfolio holdings
AUM
$683M
This Quarter Return
-12.2%
1 Year Return
+18.52%
3 Year Return
+65.11%
5 Year Return
+83.3%
10 Year Return
–
AUM
$248M
AUM Growth
+$248M
(-38%)
Cap. Flow
-$64M
Cap. Flow
% of AUM
-25.87%
Top 10 Holdings %
Top 10 Hldgs %
57.48%
Holding
689
New
67
Increased
100
Reduced
123
Closed
382
Top Buys
Top Sells
| 1 |
Tesla
TSLA
|
$58.5M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$13.3M |
| 3 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
$8.63M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
$5.33M |
| 5 |
Vanguard Value ETF
VTV
|
$3.44M |
Sector Composition
| 1 | Financials | 5.03% |
| 2 | Consumer Discretionary | 4.19% |
| 3 | Technology | 2.85% |
| 4 | Materials | 2.12% |
| 5 | Communication Services | 1.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Fidelity National Information Services
FIS
$35.6B
| $37K | 0.01% |
308
+226
| +276% | +$27.1K |
|
127
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$2.86B
| $37K | 0.01% |
617
| – | – |
|
128
Gilead Sciences
GILD
$140B
| $36K | 0.01% |
478
-9,296
| -95% | -$700K |
|
129
Centene
CNC
$14.8B
| $33K | 0.01% |
551
+299
| +119% | +$17.9K |
|
130
EPAM Systems
EPAM
$9.69B
| $32K | 0.01% |
+170
| New | +$32K |
|
131
TSMC
TSM
$1.2T
| $31K | 0.01% |
+647
| New | +$31K |
|
132
iShares Biotechnology ETF
IBB
$5.68B
| $30K | 0.01% |
275
| – | – |
|
133
Elanco Animal Health
ELAN
$8.62B
| $30K | 0.01% |
1,362
-221
| -14% | -$4.87K |
|
|
CTLT
134
DELISTED
CATALENT, INC.
CTLT
| $29K | 0.01% |
551
+46
| +9% | +$2.42K |
|
135
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$1.86B
| $29K | 0.01% |
890
+55
| +7% | +$22.2K |
|
136
Novo Nordisk
NVO
$252B
| $29K | 0.01% |
483
-194
| -29% | -$11.6K |
|
|
AGN
137
DELISTED
Allergan plc
AGN
| $26K | 0.01% |
144
-76
| -35% | -$13.7K |
|
138
Takeda Pharmaceutical
TAK
$47.8B
| $26K | 0.01% |
1,691
-815
| -33% | -$12.5K |
|
139
Elevance Health
ELV
$72.4B
| $26K | 0.01% |
114
-47
| -29% | -$10.7K |
|
140
Clorox
CLX
$15B
| $26K | 0.01% |
150
+128
| +582% | +$22.2K |
|
141
Ascendis Pharma
ASND
$12.1B
| $25K | 0.01% |
226
+36
| +19% | +$3.98K |
|
142
Sarepta Therapeutics
SRPT
$1.98B
| $24K | 0.01% |
247
+48
| +24% | +$4.66K |
|
143
3M
MMM
$81B
| $24K | 0.01% |
175
+139
| +386% | +$19.1K |
|
144
Spotify
SPOT
$143B
| $23K | 0.01% |
190
| – | – |
|
145
Cooper Companies
COO
$13.3B
| $23K | 0.01% |
82
-16
| -16% | -$4.49K |
|
|
GBT
146
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $22K | 0.01% |
437
+81
| +23% | +$4.08K |
|
|
MRTX
147
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $22K | 0.01% |
283
+78
| +38% | +$6.06K |
|
148
IQVIA
IQV
$31.4B
| $22K | 0.01% |
205
-17
| -8% | -$1.82K |
|
149
Baxter International
BAX
$12.1B
| $22K | 0.01% |
273
-825
| -75% | -$66.5K |
|
150
ICU Medical
ICUI
$3.06B
| $21K | 0.01% |
104
+8
| +8% | +$1.62K |
|